Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116143621A reveals a green boron salt catalytic method for converting benzamides to esters. This technology offers high purity, metal-free synthesis for reliable pharmaceutical intermediate supply chains.
Efficient one-step coupling method for 1-aryl-2-tetralones using ferrocene-palladium catalysts. Reduces synthetic steps and improves regioselectivity for pharmaceutical intermediates.
Novel patent CN116731087A offers high-yield Molnupiravir synthesis. Reduces toxic waste and enhances supply chain reliability for global pharmaceutical manufacturers.
Patent CN109912569B reveals a mild, high-yield route for Esomeprazole Magnesium. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN103936717B reveals a novel Delafloxacin intermediate synthesis with improved purity and yield for reliable pharmaceutical intermediates supply chains.
Patent CN1175244A reveals a novel deprotection-isomerization route for high-purity agrochemical intermediates, offering significant cost reduction and scalable manufacturing solutions.
Novel 2-step synthesis for D-p-hydroxyphenylglycine methyl ester hydrochloride. Reduces cost and waste for amoxicillin production. High purity and yield.
Advanced synthesis of Ambroxol Hydrochloride via methyl anthranilate. High yield, green chemistry, and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN104276951B reveals mild aqueous oxidation for pyruvate esters. Offers high selectivity, reusable catalysts, and supply chain stability for fine chemical manufacturing.
Patent CN107056590B details a safe industrial method for 4,4'-dimethoxytriphenylchloromethane, offering cost reduction and high purity for nucleoside manufacturing.
Patent CN107056590B reveals a safe industrial method for 4,4'-dimethoxytriphenylchloromethane. Achieve >99.9% purity with significant cost reduction in API manufacturing.
Patent CN114605272A details a novel Nickel-catalyzed asymmetric hydrogenation route for (R)-Fluoxetine intermediates, offering significant cost reduction and high enantioselectivity for API manufacturing.
Discover the advanced preparation method of Obeticholic Acid via patent CN111138509B, offering high purity, reduced impurities, and scalable manufacturing for global supply chains.
Patent CN116574072A details a green visible-light method for 2,5-diaryl furans. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel ionic liquid oxidation chlorination method ensures high purity PCMX. Green process reduces waste and enhances supply chain reliability for global buyers.
Patent CN110862368B reveals a metal-free route to benzocoumarins using blue light. Offers significant cost reduction and purity advantages for pharmaceutical intermediates.
Patent CN1376159A details a high-yield Etoposide synthesis using TMSOTf. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN118580142A reveals a low-palladium carbonylation method for diaryl ketones, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Novel fluoride-catalyzed cyanation patent reduces steps and waste. Reliable supply chain for high-purity benzonitrile derivatives for global pharmaceutical manufacturing.
Patent CN106554316A details a novel acid-catalyzed route for Olaparib intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.